Viewing StudyNCT00125723



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00125723
Status: COMPLETED
Last Update Posted: 2010-12-23
First Post: 2005-07-29

Brief Title: FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Neutropenia
Keywords:
Name View
Malignancy View
Phase 4 Clinical Trial View
Chemotherapy View
Neulasta View
Oncology View